With a focus on prevention, early detection and progressive treatment of all stages and types of lung cancer, mesothelioma and thymoma, the diagnostic and therapeutic experts at the Lung Cancer Center — one of the largest lung cancer programs in the New York metropolitan area — take an individualized approach to patient care.
The center’s multidisciplinary teams have particular expertise in complex, high-risk cancers and provide a range of state-of-the-science interventions. Seventy-five percent of the center’s surgical patients benefit from minimally invasive procedures that result in quicker recoveries and improved long term prospects.
The center’s access to clinical trials involves promising new therapies, and weekly tumor boards include consultations with multiple specialists with expertise in lung cancer.
A Team of Experts. Coordinated Lung Cancer Treatment and Care.
A multidisciplinary team of lung cancer specialists collaborates and applies leading-edge treatment options and groundbreaking technologies to deliver the most advanced personalized lung cancer care with the least physical impact on the body.
The distinguished specialists include experts in:
- Thoracic surgery
- Pulmonary medicine
- Medical oncology
- Radiation medicine
- Chest radiology
- Oncology nursing
- Oncology social services
Northwell Health is actively involved with lung cancer prevention efforts as they relate to smoking prevention. The health system maintains smoke-free facilities and campuses for the health of its patients, visitors and employees. In addition, the Northwell Health Center for Tobacco Control (CTC) is a smoking-cessation program that has helped thousands of Long Islanders quit smoking and has one of the highest success rates in the United States.
Expert Lung Cancer Diagnosis and Treatment
The Lung Cancer Center offers a wide range of options to evaluative lung cancer staging (how far the disease has progressed) and treatment.
The center’s highly experienced lung cancer specialists use minimally invasive techniques and technologies — from time-tested methods to the most advanced or alternative applications — to improve the treatment of chest and lung cancers, decrease postoperative pain and recovery time, extend survival rates and relieve symptoms for patients with certain inoperable lung tumors.
Patients receive the benefits of direct access to promising new therapies and pioneering clinical trials supported by the National Cancer Institute. Some of the studies available include:
- A national study of early stage lung cancer compares surgery with stereotactic radiation in patients with poor lung function
- A drug trial comparing initial treatment of chemotherapy with personalized therapies for anaplastic lymphoma kinase mutations